Adenocarcinome de l'endometre sous traitement contraceptif par medroxyprogesterone. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone]
Détails
ID Serval
serval:BIB_77D6CB14A2CF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Adenocarcinome de l'endometre sous traitement contraceptif par medroxyprogesterone. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone]
Périodique
Revue Médicale de la Suisse Romande
ISSN
0035-3655 (Print)
Statut éditorial
Publié
Date de publication
11/1981
Volume
101
Numéro
11
Pages
913-7
Notes
Case Reports
Journal Article --- Old month value: Nov
Journal Article --- Old month value: Nov
Mots-clé
Adenocarcinoma/*diagnosis/drug therapy
Adult
Female
Humans
*Medroxyprogesterone
Metrorrhagia/diagnosis
Uterine Neoplasms/*diagnosis/drug therapy
with injectable medroxyprogesterone acetate in January 1978, in July 1980
severe metrorrhagia appeared and continued until December 1980 when an
exploratory curettage revealed the existence of endometrial carcinoma.
This diagnosis was confirmed by hysterectomy. Cases such as the one
presented here are extremely rare, since medroxyprogesterone is commonly
used to cure endometrial cancer. It is possible, that the adenocarcinoma
was not hormone dependent since the patient was not yet menopausal, obese,
or diabetic, and the dose of medroxyprogesterone used was insufficient to
stop the evolution of the endometrial carcinoma. In the published
literature there are no cases similar to the one presented here. In case
of persistent metrorrhagia in patients treated with medroxyprogesterone
acetate, an exploratory curettage is absolutely necessary.
Pubmed
Création de la notice
25/01/2008 16:39
Dernière modification de la notice
20/08/2019 15:34
Données d'usage
